Contract Pharmaceutical Manufacturing Market Size, Share, Outlook, and Opportunity Analysis, 2018-2026

More documents

Recommendations

Info

Furthermore, stringent regulatory policies for clinical research studies and manufacturing make entire drug manufacturing process more complex, as it requires more resources to develop new drugs and biologics. These processes require expertise in broad scientific disciplines of preclinical, clinical, ancillary clinical in chemistry, packaging, manufacturing, project management, and regulatory affairs, which are provided by the CROs and CMOs. This is considered as a major reason for pharmaceutical companies to outsource clinical trials and manufacturing processes. Market Dynamics Contract manufacturing organizations (CMOs) provide wide range of manufacturing services, which include contract packaging, quality testing, and development service to pharmaceutical and biotechnology industries. Biopharmaceutical companies prefer CMOs due to the complexity involved in manufacturing process of biomolecules, as it consists of different shape, size, and behavior with significantly complex process than pharmaceutical drugs. Furthermore, by outsourcing manufacturing capabilities from contract manufacturing organization, allows recruiter firms to focus more on the research and development (R&D), product development, and marketing aspects. Pharmaceutical market is increasingly concentered with generic products and is highly competitive with various companies located in Asia Pacific, which are entering into the developed markets such as the U.S., Germany, France, and the U.K. Rising number of patents expiring in the near future serves to be a major opportunity for generic drugs manufacturers to prosper in the market. Ask For Sample Copy Of This Business Research Report : https://www.coherentmarketinsights.com/insight/request-sample/2397 Furthermore, mergers and acquisitions between generic drug manufacturers, with major players focusing on enhancing their product portfolio through inorganic strategies, will support the addition of generic drug portfolio into company’s offering and thus, generating demand for CMOs to fulfil it. For instance, in August 2016, Teva Pharmaceuticals Industries strengthened its position in the generic drugs market through acquisition of the generic segment of Allergan, plc for US$ 40.5 billion. This resulted in significant growth in revenue contribution of its generic drug segment, pegged at US$ 9.5 billion in 2016.
Detailed Segmentation: •Global contract pharmaceutical manufacturing market, By Service Type: •Contract Manufacturing Organization (CMO) •API Manufacturing •Final dosage form manufacturing •Packaging •Contract Research Organization (CRO) •Drug Discovery •Preclinical studies •Early Phase I - IIa •Phase IIa - III •Phase IIIb - IV •Medical coding and writing •Monitoring •Clinical Data Management •Bio-statistics •Site management •Protocol development •Global Contract Pharmaceutical Manufacturing Market, By Molecule Type: •Small Molecules •Large Molecules
Page 1: Contract Pharmaceutical Manufacturi

Contract Pharmaceutical Manufacturing Market Size, Share, Outlook, and Opportunity Analysis, 2018-2026

Create successful ePaper yourself

Delete template?

Save as template?